Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$12.40 USD
+0.42 (3.51%)
Updated May 17, 2024 04:00 PM ET
After-Market: $12.25 -0.15 (-1.21%) 7:58 PM ET
C Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DTIL 12.40 +0.42(3.51%)
Will DTIL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DTIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DTIL
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates
Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
DTIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precision BioSciences (DTIL) Now Trades Above Golden Cross: Time to Buy?
Wall Street Analysts Predict a 407.94% Upside in Precision BioSciences (DTIL): Here's What You Should Know
Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?
Other News for DTIL
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Biotech Alert: Searches spiking for these stocks today
Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
Analysts Offer Insights on Healthcare Companies: Precision BioSciences (DTIL) and Adicet Bio (ACET)
Maintaining Hold on Precision BioSciences Pending Clinical Data and Strategic Reassessments